Murashko: prices for vital drugs increased by 2.3% over the year
[ad_1]
The cost of vital and essential drugs (VED) increased by 2.3% over the year, said Head of the Ministry of Health Mikhail Murashko. According to the forecast of the Central Bank, the general inflation in the Russian Federation at the end of the year will be 12-13%.
“Inflationary changes in the prices of VED drugs 2.3%. This is significantly lower than the inflation rate in the country,” Mr. Murashko said. “RIA News”.
FAS in early November informedthat margins on socially important goods in Russian retail chains have decreased from 22% to 6%. It was alleged that the re-registration of prices for vital and essential drugs made it possible to reduce the cost of half of the drugs from this list by 30%.
In Russia, after the start of the military operation in Ukraine, there are difficulties with the supply of certain drugs. For example, patients with Parkinson’s disease reported about the shortage of vital drugs based on levodopa. According to RNC Pharma, the supply of these drugs has decreased by 49% in a year. Movement “Patient Control” warned about the shortage of the most popular and most expensive combined (three drugs in one tablet) on the domestic market of the antiretroviral drug “Eviplera”.
On the prospects of the Russian market for Asian pharmaceutical companies – in the material “Kommersant” “With double energy”.
[ad_2]
Source link
